Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody in Patients with Microsatellite Stable Colorectal Cancer Life Science Investing
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease in The New England Journal of Medicine Life Science Investing
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease in The New England Journal of Medicine Life Science Investing
RenovoRx Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 Life Science Investing
Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting Technology Investing
